newsfilter
← Latest News
GlobeNewswire·

PharmaTher Holdings Announces Grant of U.S. Patent Covering Ketamine for Parkinson's Disease

Grant of US patent strengthens the PharmaTher's intellectual property portfolio covering novel uses and delivery forms of ketamine Announced positive efficacy and safety data from Phase 1/2 clinical study of ketamine in the treatment of levodopa-induc